Cellular and subcellular components within cancer cells

The term "Cellular and subcellular components within cancer cells" is a broad descriptive category rather than a specific molecular target. It encompasses the various organelles and structural elements—such as the nucleus, mitochondria, endoplasmic reticulum, and cytoskeleton—that are essential for the survival and proliferation of malignant cells (Cooper, 2000, The Cell: A Molecular Approach). In oncology, therapeutic agents are designed to exploit the physiological differences between these components in cancerous versus healthy cells. For example, DNA-damaging agents target the nucleus, while BH3 mimetics target the mitochondrial apoptotic machinery (Hanahan & Weinberg, 2011, Cell). Because this term covers a vast range of distinct biological entities and pathways, it is considered too non-specific for standard target annotation in drug discovery. Effective therapeutic strategies involve targeting specific proteins or processes within these components to induce cell death while minimizing damage to healthy tissues (NIH, 2023). Consequently, while these components are the focus of cancer therapy, the term itself represents a collection of targets rather than a single therapeutic entity.

Other names

Intracellular cancer targetsSubcellular organelles in cancer cellsCancer cell architecture

Drugs targeting these components act through diverse mechanisms: DNA intercalators and alkylating agents disrupt nuclear function; taxanes and vinca alkaloids interfere with the cytoskeleton; BH3 mimetics trigger mitochondrial apoptosis; and proteasome inhibitors disrupt protein homeostasis (Hanahan & Weinberg, 2011).